Table 2.
Characteristics of patients with subarachnoid hemorrhage from brain aneurysm rupture 2008–2015 by discharge to home, n = 118.
| Characteristic | Discharge home, n = 53 | Discharge to Other location, n = 65 | p-Valuea |
|---|---|---|---|
| Age, mean (SD) | 51.3 (11.1) | 59.4 (12.4) | <0.001 |
| Female, n (%) | 34 (64.2) | 43 (66.2) | 0.82 |
| History of tobacco use, n (%) | 25 (47.2) | 39 (60.0) | 0.16 |
| History of hypertension, n (%) | 27 (50.9) | 46 (70.8) | 0.03 |
| History of statin use, n (%) | 3 (5.7) | 5 (7.7) | 0.66 |
| History of cocaine use, n (%) | 1 (1.9) | 2 (3.1) | >0.99 |
| History of marijuana use, n (%) | 4 (7.6) | 4 (6.2) | >0.99 |
| WFNS, n (%) | <0.001 | ||
| 1 | 21 (39.6) | 10 (15.4) | |
| 2 | 20 (37.7) | 14 (21.5) | |
| 3 | 0 | 1 (1.5) | |
| 4 | 10 (18.9) | 31 (47.7) | |
| 5 | 2 (3.8) | 9 (13.9) | |
| GCS motor score, n (%) | 0.003 | ||
| 6 | 46 (87) | 35 (54) | |
| 5 | 5 (9) | 20 (31) | |
| 4 | 2 (4) | 4 (6) | |
| <4 | 0 | 6 (9) | |
| MFS, n (%) | 0.002 | ||
| 2 | 5 (9.4) | 4 (6.2) | |
| 3 | 46 (86.8) | 42 (64.6) | |
| 4 | 2 (3.8) | 19 (29.2) | |
| Aneurysm location, n (%)b | 0.39 | ||
| Internal carotid artery | 12 (23) | 19 (29) | |
| Anterior cerebral artery | 22 (42) | 32 (49) | |
| Middle cerebral artery | 15 (28) | 11 (17) | |
| Posterior circulation | 4 (8) | 3 (5) | |
| Procedure type, n (%) | 0.18 | ||
| Clip | 51 (96.2) | 57 (87.7) | |
| Coil | 2 (3.8) | 8 (12.3) | |
| >20 h to surgery, n (%) | 18 (34.0) | 26 (40.0) | 0.50 |
| Nimodipine compliance, n (%) | 5 (8) | 0.18 | |
| All doses received | 15 (28) | 5 (8) | |
| At least one dose split | 4 (8) | 2 (3) | |
| At least one dose missed | 34 (64) | 58 (89) | |
| Vasospasm severity, n (%) | 0.05 | ||
| none | 21 (39.6) | 18 (27.9) | |
| mild | 12 (22.6) | 10 (15.4) | |
| moderate | 14 (26.4) | 16 (24.6) | |
| severe | 6 (11.3) | 21 (32.3) | |
| VIH, n (%) | 12 (22.6) | 40 (61.5) | <0.001 |
| Systolic blood pressure, mean (SD) | 134.5 (20.0) | 152.4 (15.3) | <0.001 |
| Days on pressors, M (IQR) | 0 (0,0) | 2.0 (0, 6.0) | <0.001 |
| IAT needed, n (%) | 3 (5.7) | 20 (30.8) | <0.001 |
| Angioplasty, n (%) | 0 | 6 (9.2) | 0.02 |
| DND, n (%) | 12 (22.6) | 43 (66.2) | <0.001 |
| CTinfarction, n (%) | 1 (1.9) | 13 (20.0) | 0.003 |
| Shunt inserted, n (%) | 9 (17.0) | 22 (33.9) | 0.04 |
| ICU length of stay, mean (SD) | 15.5 (5.4) | 22.8 (10.2) | <0.001 |
| GOS > 3, n (%) | 53 (100) | 36 (55.4) | <0.001 |
| Died, n (%) | 0 | 7 (10.8) | 0.01 |
ap-Value from Chi-square Goodness of Fit, Student’s t-test, or Wilcoxon rank sum.
WFNS, World Federation of Neurosurgical Societies Scale; GCS, Glasgow Coma Scale; MFS, Modified Fisher Scale; DND, delayed neurological deficit; VIH, vassopressor-induced hypertension; IAT, intra-arterial treatment; ICU, intensive care unit; GOS, Glasgow Outcomes Scale.
bAneurysms by location: anterior cerebral artery (A1, anterior communicating artery, A2 and pericallosal aneurysms); middle cerebral artery; internal carotid artery (anterior choroidal artery, posterior communicating artery, and carotid terminus aneurysms); posterior circulation (vertebral artery, basilar artery, posterior inferior cerebellar artery, anterior inferior cerebellar artery and superior cerebellar artery aneurysms).